AccuraGen
PrivateLast Round
Series B
Jun 1, 2016
Total Funding Raised
$46.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AccuraGen operates in Healthcare & Life Sciences and is based in San Jose, California. Its latest recorded funding round was a Series B round in June 2016.
AccuraGen is a biotechnology company that develops liquid biopsy technology for personalized cancer treatment and disease monitoring.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AccuraGen Comparables
Compare AccuraGen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Predicine | 84% | |
| Quest Diagnostics | 79% | |
| Personalis Inc | 78% |
For institutional investors. Book with your work email.
AccuraGen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 1, 2016 | ||||
| Series A | Feb 6, 2015 |
For institutional investors. Book with your work email.
AccuraGen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Temasek | Series B |
| StartX | Series B |
| Junson Capital | Series B |
| DT Capital Partners | Series B |
| DT Capital Limited | Series B |
| Nan Fung Group (Investment Arm) | Series B |
| Decheng Capital | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 22, 2x the trailing average.
- Jun 1, 2016
$40M round with participation from Temasek and Nan Fung Group.
For institutional investors. Book with your work email.
AccuraGen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AccuraGen's valuation, stock price, and market status.
Is AccuraGen a public or private company?
AccuraGen is a private company.
What is the current stock price of AccuraGen?
AccuraGen is a private company, so its shares have no public market price. Caplight tracks AccuraGen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AccuraGen worth (valuation)?
Valuation information for AccuraGen is not publicly available.
Can I buy AccuraGen stock?
AccuraGen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AccuraGen's last funding round?
AccuraGen's most recent funding round was Series B on June 1, 2016.
Who are the main investors in AccuraGen?
Key investors in AccuraGen include Decheng Capital.
Will AccuraGen IPO soon?
No public IPO plans have been announced for AccuraGen.
How can I track AccuraGen secondary market activity?
Caplight tracks bids, offers, and trades in AccuraGen's shares on secondary markets.